Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Proceedings of the National Academy of Sciences of the United States of America
|
January 30, 2025
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variants
Hannah A D King, Daniel Brammer, Eric Lewitus, et al.
Plos Pathogens
|
December 6, 2023
Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States
Lindsay Wieczorek, Eric Sanders-Buell, Michelle Zemil, et al.
Nature Communications
|
May 9, 2024
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding
Hongjun Bai, Eric Lewitus, Yifan Li, et al.
Plos Pathogens
|
February 7, 2020
Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand
Morgane Rolland, Sodsai Tovanabutra, Bethany Dearlove, et al.
Virus Evolution
|
September 17, 2021
RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection
Eric Lewitus, Eric Sanders-Buell, Meera Bose, et al.
Nature Communications
|
February 3, 2023
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
Wei-Hung Chen, Agnes Hajduczki, Elizabeth J Martinez, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Proceedings of the National Academy of Sciences of the United States of America
|
January 30, 2025
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variants
Hannah A D King, Daniel Brammer, Eric Lewitus, et al.
Plos Pathogens
|
December 6, 2023
Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States
Lindsay Wieczorek, Eric Sanders-Buell, Michelle Zemil, et al.
Nature Communications
|
May 9, 2024
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding
Hongjun Bai, Eric Lewitus, Yifan Li, et al.
Plos Pathogens
|
February 7, 2020
Molecular dating and viral load growth rates suggested that the eclipse phase lasted about a week in HIV-1 infected adults in East Africa and Thailand
Morgane Rolland, Sodsai Tovanabutra, Bethany Dearlove, et al.
Virus Evolution
|
September 17, 2021
RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infection
Eric Lewitus, Eric Sanders-Buell, Meera Bose, et al.
Nature Communications
|
February 3, 2023
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
Wei-Hung Chen, Agnes Hajduczki, Elizabeth J Martinez, et al.
Page
of 4